01998nam a2200217   4500001000700000100004100007101000800048200012600056210006700182215002000249225001900269300004800288330121300336606002201549606002601571606002301597606001801620606003101638606002201669710008901691394852  a20171219d2017       y0pory50      ba  aeng  a2017 global synthetic drugs assessmentbRecurso eletrónicoeamphetamine-type stimulants and new psychoactive substances  aViennacUnited Nations Office on Drugs and Crime (UNODC)d2017  a1 CD-ROMd12 cm  aUNODC Research  aFicheiro de 2,97 MB em formato PDF (81 p.).  aExplanatory notes. Key findings. Global overview. A. Africa. B. Central and Southwest Asia. C. East and South-East Asia and Oceania. D. Europe. E. Near and Middle East. F. North and Central America. G. South America. Market analysis of synthetic drugs. Introduction. A. Amphetamine-type stimulants. A.1. Amphetamine-type stimulants: market developments. A.2. Methamphetamine: a dynamic global market. A.3. Amphetamine trafficking is spreading. A.4. “Ecstasy”. B. New psychoactive substances and other synthetic drugs. B.1. New psychoactive substances: market developments. B.2. Characteristics of new psychoactive substances users and trends in new psychoactive substances use. B.3. How well-informed are users of new psychoactive substances and how concerned are they about what they are using? B.4. Health risks of new psychoactive substances with stimulant effects. B.5. Synthetic cannabinoids: toxicity and fatalities. B.6. Use of hallucinogenic new psychoactive substances is increasing in South America. B.7. Synthetic opioids: the resurgence of fentanyl and its analogues. B.8. GBL: a ready source of GHB? B.9. Ketamine supply is increasing in South-East Asia. ANNEX. Glossary. Regional groupings.  aDROGA SINTÉTICA  aPRODUÇÃO DE DROGA  aTRÁFICO DE DROGA  aROTA DE DROGA  aESTATÍSTICAS SOBRE DROGA  aRELATÓRIO ANUAL  aNAÇÕES UNIDASbOffice on Drugs and Crime. UNODC Laboratory and ScientificSection